Mutual of America Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,221
| Closed | -$73.9K | – | 1485 |
|
|
2023
Q2 | $73.9K | Sell |
11,221
-473
| -4% | -$3.12K | ﹤0.01% | 1462 |
|
|
2023
Q1 | $79.4K | Sell |
11,694
-166
| -1% | -$1.13K | ﹤0.01% | 1454 |
|
|
2022
Q4 | $87.6K | Buy |
11,860
+607
| +5% | +$4.49K | ﹤0.01% | 1440 |
|
|
2022
Q3 | $111K | Buy |
11,253
+1,765
| +19% | +$17.4K | ﹤0.01% | 1509 |
|
|
2022
Q2 | $103K | Buy |
9,488
+1,460
| +18% | +$15.8K | ﹤0.01% | 1494 |
|
|
2022
Q1 | $91K | Buy |
8,028
+416
| +5% | +$4.72K | ﹤0.01% | 1541 |
|
|
2021
Q4 | $119K | Buy |
7,612
+192
| +3% | +$3K | ﹤0.01% | 1490 |
|
|
2021
Q3 | $127K | Sell |
7,420
-479
| -6% | -$8.2K | ﹤0.01% | 1472 |
|
|
2021
Q2 | $170K | Buy |
7,899
+570
| +8% | +$12.3K | ﹤0.01% | 1423 |
|
|
2021
Q1 | $110K | Buy |
7,329
+469
| +7% | +$7.04K | ﹤0.01% | 1525 |
|
|
2020
Q4 | $90K | Buy |
6,860
+278
| +4% | +$3.65K | ﹤0.01% | 1507 |
|
|
2020
Q3 | $64K | Buy |
6,582
+3,941
| +149% | +$38.3K | ﹤0.01% | 1503 |
|
|
2020
Q2 | $30K | Buy |
2,641
+325
| +14% | +$3.69K | ﹤0.01% | 1467 |
|
|
2020
Q1 | $24K | Buy |
2,316
+423
| +22% | +$4.38K | ﹤0.01% | 1456 |
|
|
2019
Q4 | $31K | Sell |
1,893
-72
| -4% | -$1.18K | ﹤0.01% | 1472 |
|
|
2019
Q3 | $26K | Buy |
1,965
+67
| +4% | +$887 | ﹤0.01% | 1514 |
|
|
2019
Q2 | $27K | Buy |
1,898
+383
| +25% | +$5.45K | ﹤0.01% | 1499 |
|
|
2019
Q1 | $28K | Buy |
1,515
+213
| +16% | +$3.94K | ﹤0.01% | 1445 |
|
|
2018
Q4 | $34K | Buy |
+1,302
| New | +$34K | ﹤0.01% | 1334 |
|